|
ABOS
|
Acumen Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
ACIU
|
AC Immune SA
|
US
|
NASDAQ
|
|
ALZN
|
Alzamend Neuro, Inc.
|
US
|
NASDAQ
|
|
ANVS
|
Annovis Bio, Inc.
|
US
|
NYSE
|
|
CCCC
|
C4 Therapeutics, Inc.
|
US
|
NASDAQ
|
|
DNLI
|
Denali Therapeutics Inc.
|
US
|
NASDAQ
|
|
ITCI
|
Intra-Cellular Therapies Inc.
|
US
|
NASDAQ
|
|
MITO
|
Stealth BioTherapeutics Corp.
|
US
|
NASDAQ
|
|
NRBO
|
NeuroBo Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
NRSN
|
NeuroSense Therapeutics Ltd.
|
US
|
NASDAQ
|
|
PRTA
|
Prothena Corporation plc
|
US
|
NASDAQ
|
|
SNPX
|
Synaptogenix, Inc.
|
US
|
NASDAQ
|
|
ATH
|
Alterity Therapeutics Limited
|
AU
|
ASX
|
|
NSB
|
NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD
|
AU
|
ASX
|
|
BIOAF
|
Bioasis Technologies
|
US
|
OTC
|
|
PMN
|
ProMIS Neurosciences Inc.
|
CA
|
TSX
|
|
ORPHA
|
Orphazyme A/S
|
DK
|
CO
|
|
HRTIS
|
Herantis Pharma Oyj
|
FI
|
HE
|
|
ALPHA
|
Pharnext SA
|
FR
|
PA
|
|
KDST
|
Kadimastem Ltd
|
IL
|
TA
|